title: C1q nephropathy: features at presentation and outcome.
abstract: The study population comprised all 20 patients followed since 1990 through December 2004 at the Le Bonheur Children's Medical Center with diagnosis of C1q nephropathy (55% boys; 60% African Americans). All were aged under 18 years at biopsy (mean 11.2 years, 65% aged 11 or over); the youngest presented at age 10 months and progressed to end-stage renal disease at 14 months. None had clinical or laboratory features of systemic lupus erythematosis or membranoproliferative glomerulonephritis. Clinical features assessed at diagnosis were age, gender, blood pressure, history of macroscopic hematuria, urinary protein to creatinine ratio, serum creatinine, estimated glomerular filtration rate, renal histology, and pattern for immunofluorescent reactants. At the time of biopsy 40% had nephrotic syndrome and 30% nephrotic range proteinuria without nephrotic syndrome. Three patients with nephrotic syndrome also had chronic renal insufficiency at diagnosis. The most common histological feature was focal segmental glomerulosclerosis in 40%, but 30% had minimal change lesion. Four patients, all with nephrotic syndrome at diagnosis, progressed to end-stage renal disease. Of the 12 patients not presenting with nephrotic syndrome, none had chronic renal insufficiency at last follow-up. Kidney survival was 94% and 78% at 1 and 5 years, respectively, in all patients and 88% and 49% in those presenting with nephrotic syndrome.
authors.affiliation: Children's Foundation Research Center, Le Bonheur Children's Medical Center, Memphis, TN 38103, USA.
authors.forename: Keith K
authors.initials: KK
authors.lastname: Lau
authors.forename: Lillian W
authors.initials: LW
authors.lastname: Gaber
authors.forename: Noel M
authors.initials: NM
authors.lastname: Delos Santos
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Wyatt
mesh_terms: D000293:Adolescent; D002648:Child; D015922:Complement C1q / Q000378:metabolism*; D018450:Disease Progression; D005260:Female; D005921:Glomerulonephritis / Q000150:complications* / Q000378:metabolism*; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology*; D006801:Humans; D007223:Infant; D007676:Kidney Failure, Chronic / Q000209:etiology*; D008297:Male; D009402:Nephrosis, Lipoid / Q000209:etiology; D009404:Nephrotic Syndrome / Q000209:etiology* / Q000503:physiopathology; D011507:Proteinuria / Q000209:etiology*; D014022:Tissue Survival
chemical_list: D015922:Complement C1q